VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer
NCT01579591
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
OTHER:
VSL#3
OTHER:
Placebo
Sponsor
Catholic University of the Sacred Heart